Pharmaceutical Contract Manufacturing: The Solution to Production of Complex Substances

Pharma

The inherent expertise of CMOs and CDMOs is believed to be capable of enabling reduction in the time-to-market a product, significant cost-benefits, as well as access to larger production capacities and novel technologies.  It is worth mentioning that there has been substantial merger and acquisition activity in the pharmaceutical contract manufacturing market in the past few years, as players strive to become one stop shops, in order to cater to the diverse needs of pharmaceutical developers (ranging from early-stage development to commercial production). Considering the ongoing innovation in production technologies, evolving pipeline of small molecule products and the increasing demand for such drug candidates, we believe that the pharmaceutical contract manufacturing market is likely to witness positive growth in the coming years.

Players Engaged in Offering Contract Manufacturing Services

Close to 500 companies claim to offer contract manufacturing services to pharmaceutical companies across the globe

Players Engaged in Offering Contract Manufacturing Services

Geographical Location of Manufacturing Facilities

Majority of the contract manufacturing facilities are located in Asia-Pacific region, followed by Europe and North America.

Geographical Location of Manufacturing Facilities

More Than USD 9 Billion has been Invested by Pharmaceutical CMOs for Expansion of their Capacities / Capabilities across the Globe between 2017 and 2021

The last five years have witnessed ample increase in the number of expansion initiatives undertaken by pharmaceutical CMOs to expand development and manufacturing operations.

More Than USD 9 Billion has been Invested by Pharmaceutical CMOs
The Pharmaceutical Contract Manufacturing Market is anticipated to grow at a CAGR of 6.7%, during 2021-2030

Owing to the rising competition among pharmaceutical companies and pressing need to reduce drug development timelines, the pharmaceutical contract manufacturing market is anticipated to witness ample increase in the coming decade.

The Pharmaceutical Contract Manufacturing Market is anticipated to grow at a CAGR of 6.7%

To get a detailed information on the key players, regulatory landscape, mergers and acquisitions, expansions, demand, installed capacity and the likely market evolution, visit this link

For further information on this domain, check out the report

Pharmaceutical Contract Manufacturing Market

You may also be interested in the following titles:

  1. Progressive Supranuclear Palsy: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
  2. Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030
  3. Bronchial Spasm: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031

Our Social Media Platform

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.